PMH32 COMPARISON OF REAL-WORLD HEALTH CARE COSTS AFTER THE INITIATION OF SECOND-LINE DULOXETINE OR GENERIC SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH MAJOR DEPRESSIIVE DISORDER
May 1, 2011, 00:00
10.1016/j.jval.2011.02.1056
https://www.valueinhealthjournal.com/article/S1098-3015(11)01195-8/fulltext
Title :
PMH32 COMPARISON OF REAL-WORLD HEALTH CARE COSTS AFTER THE INITIATION OF SECOND-LINE DULOXETINE OR GENERIC SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH MAJOR DEPRESSIIVE DISORDER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01195-8&doi=10.1016/j.jval.2011.02.1056
First page :
A191
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
542